These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 24973341)

  • 1. Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
    Lukas C; Knol DL; Sombekke MH; Bellenberg B; Hahn HK; Popescu V; Weier K; Radue EW; Gass A; Kappos L; Naegelin Y; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):410-8. PubMed ID: 24973341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
    Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.
    Lin X; Tench CR; Turner B; Blumhardt LD; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1090-4. PubMed ID: 12876240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. Correlation between MRI parameters and clinical course.
    Bonek R; Orlicka K; Maciejek Z
    Neurol Neurochir Pol; 2007; 41(3):229-33. PubMed ID: 17629816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.
    Hagström IT; Schneider R; Bellenberg B; Salmen A; Weiler F; Köster O; Gold R; Lukas C
    J Neurol; 2017 Jul; 264(7):1402-1412. PubMed ID: 28600596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.
    Cawley N; Tur C; Prados F; Plantone D; Kearney H; Abdel-Aziz K; Ourselin S; Wheeler-Kingshott CAG; Miller DH; Thompson AJ; Ciccarelli O
    Mult Scler; 2018 Jun; 24(7):932-941. PubMed ID: 28516804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal cord volume loss: A marker of disease progression in multiple sclerosis.
    Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
    Neurology; 2018 Jul; 91(4):e349-e358. PubMed ID: 29950437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
    Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
    Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients.
    Lukas C; Sombekke MH; Bellenberg B; Hahn HK; Popescu V; Bendfeldt K; Radue EW; Gass A; Borgwardt SJ; Kappos L; Naegelin Y; Knol DL; Polman CH; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2013 Nov; 269(2):542-52. PubMed ID: 23737540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential spinal cord volume loss in primary progressive multiple sclerosis.
    Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
    Mult Scler; 2019 Jun; 25(7):947-957. PubMed ID: 29781383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
    Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cord lesion load is associated with disability independently from atrophy in MS.
    Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: A two-year longitudinal study.
    Weeda MM; Zywicki S; Brouwer I; Moraal B; Killestein J; Gallo P; Barkhof F; Pouwels PJW; Vrenken H
    Mult Scler Relat Disord; 2022 Apr; 60():103713. PubMed ID: 35272146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Casserly C; Seyman EE; Alcaide-Leon P; Guenette M; Lyons C; Sankar S; Svendrovski A; Baral S; Oh J
    J Neuroimaging; 2018 Nov; 28(6):556-586. PubMed ID: 30102003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis--a quantitative T1 relaxation time mapping approach.
    Vaithianathar L; Tench CR; Morgan PS; Constantinescu CS
    J Neurol; 2003 Mar; 250(3):307-15. PubMed ID: 12638021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability.
    Valsasina P; Aboulwafa M; Preziosa P; Messina R; Falini A; Comi G; Filippi M; Rocca MA
    Radiology; 2018 Jul; 288(1):234-244. PubMed ID: 29664341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.